Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.000
+0.160 (4.17%)
At close: Jan 22, 2026, 4:00 PM EST
4.080
+0.080 (2.00%)
After-hours: Jan 22, 2026, 6:46 PM EST
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $509.55 million as of January 22, 2026. Its market cap has increased by 30.74% in one year.
Market Cap
509.55M
Enterprise Value
486.62M
1-Year Change
30.74%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $509.55M, a decrease of -58.79%. That is a compound annual growth rate of -11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 487.34M | -25.87% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 693.53M |
| Esperion Therapeutics | 680.39M |
| Emergent BioSolutions | 582.97M |
| SIGA Technologies | 468.34M |
| Kamada | 453.85M |
| Canopy Growth | 429.13M |
| Aquestive Therapeutics | 424.57M |
| Eton Pharmaceuticals | 411.92M |